Top MES Software Company For Pharma Manufacturing Software
Pharmaceutical manufacturers are under continuous pressure to remain competitive while meeting the stringent regulatory manufacturing requirements. These manufacturing requirements range from simple electronic record keeping to complex data assuring consistently the reliability of the manufacturing processes, equipment and people’s training, rawmaterialquality,samplingplans,root-cause-analysis,product’sdeviations,etc.
About manufacturersPharmaceuticalSoftware
About manufacturersPharmaceuticalSoftware
Atachi Systems’ experience in deploying MES for pharmaceutical manufacturing companies for several years in a row is a testimonial on its own. Put simply, Atachi Systems understands the importance of deploying an MES system that is strategic to its core manufacturing requirements, yet cost effective to maintain and run for years to come! Our clients call it the AtachiAdvantage.
functionalitiesperformanceadvantageconfirmsERP.NGIMESunderstandAtachiSystemisthetopMESsoftwarecompanyforPharmaceuticalmanufacturers.WetheimportanceofdeployinganMESsystemforPharmaceuticalmanufacturers.isthe“premiere”MESforpharmaceuticalmanufacturingcompaniesthatusesSAPIthelpscomplywith21CFRPart11electronicsignatures,FDAaudits,validationandtoUSFDAcGMPrequirements.Furthermore,pharmaceuticalcompaniescantakeofthecloudbasedMES(NGIMES)tocontaincostswhiledeliveringacceleratedwithitsin-memorycomputingplatform.BelowimagecoversalltheMESdetailedinISA-95modelthatAtachiNGIMESbrings. About manufacturersPharmaceuticalSoftware
Lately few API (Active Pharmaceutical Ingredients) manufacturers have been getting the FDA warning letters for not being able to prove that their API is stable through the stability period. Lot of times the manufacturers face the critical challenges in providing the required
structurereducesOurpreventedvariousdocumentationthatdoesn’ttiewellintothedataintegrityoftheAPIstability.TherecouldbereasonshowanAPIstabilitygotaffectedandwhichcouldhavebeeneasilyandsavedlotofproductrecallsandavoidedthedrugshortagesintothemarket.belowslidegivesasimplisticprocessthatcouldavoidtheAPIstabilityissuesandtheFDAauditresponsetimestoaslowasanhourprovidedtheappropriatesystemisimplemented. API stability for Active PharmaceuticalManufacturersIngredient
